UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): August 10, 2017 (August 10, 2017)
Global Medical REIT Inc.
(Exact name of registrant as specified in its charter)
| Maryland | 001-37815 | 46-4757266 |
|
(State or Other Jurisdiction of Incorporation) |
(Commission File Number) |
(I.R.S. Employer Identification No.) |
4800 Montgomery Lane, Suite 450
Bethesda, MD
20814
(Address of Principal Executive Offices)
(Zip Code)
(202) 524-6851
(Registrant’s Telephone Number, Including Area Code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company x
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
| Item 2.02 | Results of Operations and Financial Condition. |
On August 10, 2017, Global Medical REIT Inc. (the “Company”) issued a press release announcing the Company’s financial position as of June 30, 2017, and operating results for the three and six-month periods ended June 30, 2017 and other related information. A copy of the press release has been furnished as Exhibit 99.1 to this Current Report on Form 8-K, and is incorporated herein by reference.
| Item 7.01 | Regulation FD Disclosure. |
On August 10, 2017, the Company made available on its website information concerning the Company’s property portfolio as of June 30, 2017 and other related information in a document entitled “Global Medical REIT Supplemental Portfolio Information – Second Quarter – June 30, 2017.” A copy of this document has been furnished as Exhibit 99.2 to this Current Report on Form 8-K, and is incorporated herein by reference.
The information included in Items 2.02 and 7.01 of this Current Report on Form 8-K and the exhibits related thereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities of that section, and shall not be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing.
| Item 9.01 | Financial Statement and Exhibits. |
| (d) | Exhibits. |
| Exhibit No. | Description | |
| 99.1 | Press release dated August 10, 2017. | |
| 99.2 | Global Medical REIT Supplemental Portfolio Information – Second Quarter – June 30, 2017. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Global Medical REIT Inc. | ||
| By: | /s/ Jamie A. Barber | |
| Jamie A. Barber | ||
| Secretary and General Counsel | ||
Dated: August 10, 2017
EXHIBIT INDEX
| Exhibit No. | Description | |
| 99.1 | Press release dated August 10, 2017. | |
| 99.2 | Global Medical REIT Supplemental Portfolio Information – Second Quarter – June 30, 2017. |